| Product Code: ETC8923507 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, North Macedonia continued to heavily rely on imports of carbapenem, with top exporting countries including India, China, Spain, Netherlands, and Italy. The market remained highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) for carbapenem imports from 2020 to 2024 was an impressive 21.39%, with a notable growth rate of 8.09% from 2023 to 2024. This data suggests a sustained demand for carbapenem in North Macedonia, with key players from various countries contributing to the market`s growth.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Macedonia Carbapenem Market Overview |
3.1 Republic of Macedonia Country Macro Economic Indicators |
3.2 Republic of Macedonia Carbapenem Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Macedonia Carbapenem Market - Industry Life Cycle |
3.4 Republic of Macedonia Carbapenem Market - Porter's Five Forces |
3.5 Republic of Macedonia Carbapenem Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Republic of Macedonia Carbapenem Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Republic of Macedonia Carbapenem Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Republic of Macedonia Carbapenem Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in the Republic of Macedonia |
4.2.2 Rising awareness about the effectiveness of carbapenem antibiotics |
4.2.3 Growing healthcare infrastructure and expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for antibiotic usage |
4.3.2 High cost associated with carbapenem antibiotics |
4.3.3 Increasing concerns about antibiotic resistance |
5 Republic of Macedonia Carbapenem Market Trends |
6 Republic of Macedonia Carbapenem Market, By Types |
6.1 Republic of Macedonia Carbapenem Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Republic of Macedonia Carbapenem Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Republic of Macedonia Carbapenem Market Revenues & Volume, By Meropenem, 2021- 2031F |
6.1.4 Republic of Macedonia Carbapenem Market Revenues & Volume, By Imipenem, 2021- 2031F |
6.1.5 Republic of Macedonia Carbapenem Market Revenues & Volume, By Ertapenem, 2021- 2031F |
6.2 Republic of Macedonia Carbapenem Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Republic of Macedonia Carbapenem Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Republic of Macedonia Carbapenem Market Revenues & Volume, By Bloodstream Infections, 2021- 2031F |
6.2.4 Republic of Macedonia Carbapenem Market Revenues & Volume, By Intra-abdominal Infections, 2021- 2031F |
6.2.5 Republic of Macedonia Carbapenem Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.3 Republic of Macedonia Carbapenem Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Republic of Macedonia Carbapenem Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Republic of Macedonia Carbapenem Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
7 Republic of Macedonia Carbapenem Market Import-Export Trade Statistics |
7.1 Republic of Macedonia Carbapenem Market Export to Major Countries |
7.2 Republic of Macedonia Carbapenem Market Imports from Major Countries |
8 Republic of Macedonia Carbapenem Market Key Performance Indicators |
8.1 Rate of antibiotic-resistant infections in the Republic of Macedonia |
8.2 Number of healthcare facilities adopting carbapenem antibiotics |
8.3 Percentage of physicians recommending carbapenem antibiotics for serious infections |
8.4 Investment in research and development of new carbapenem antibiotics |
8.5 Number of reported adverse effects associated with carbapenem antibiotic usage |
9 Republic of Macedonia Carbapenem Market - Opportunity Assessment |
9.1 Republic of Macedonia Carbapenem Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Republic of Macedonia Carbapenem Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Republic of Macedonia Carbapenem Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Republic of Macedonia Carbapenem Market - Competitive Landscape |
10.1 Republic of Macedonia Carbapenem Market Revenue Share, By Companies, 2024 |
10.2 Republic of Macedonia Carbapenem Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |